First US Patient Enrolled in SELUTION SLR IDE Peripheral Study
1st US Patient Now Enrolled in SELUTION SLR IDE Peripheral Study
The aim of the SELUTION4BTK clinical trial is to demonstrate the superior efficacy and equivalent safety of SELUTION SLR compared to plain (uncoated) balloon angioplasty (POBA) in the treatment of BTK arteries in Chronic Limb Threatening Ischemia (CLTI) patients.